BioMedHeparin Anti-Xa肝素(抗因子Xa)221003点击次数:1199发布时间:2014/7/21价格:￥1500 更新日期:2024/8/5 18:39:26 生产地:中国大陆 产品型号: 简单介绍:BioMed 常用的发色底物 法国HYPHEN BioMed公司(简称HBM)--欧洲知名血液产品生产商,通过ISO9001和ISO13485双项认证,生产的大部分产品均通过欧洲CE认证,为...
获取该产品"Heparin Anti-Xa肝素(抗因子Xa)(2 stages)221010"联系方式如下 方案2 第一步:用微信扫描二维码,关注阿仪网公众账号 第二步:在微信上输入pro4437746即可获取电话 第三步:获取后您可以直接拨打电话号码 我要推广 优质信息推广广告 耐电弧试验仪价格 ...
Certain patient populations (pregnancy, cancer, renal impairment, and obesity) may be at higher risk of adverse events during low molecular weight heparin (LMWH) therapy and may benefit from anti-Xa monitoring. Yet, evidence supporting a standardized approach to anti-Xa monitoring correlated to ...
In the derivation cohort, heparin anti-Xa activity ≤0.2, ≤0.3, <0.1, <0.1 IU·mL reliably ruled out a relevant level of apixaban, rivaroxaban, fondaparinux, and danaparoid, respectively (area under the ROC curve ≥0.99). In the validation cohort, these cutoffs yielded excellent ...
BIOPHEN AT (Anti‐IIa) 2x2.5 ml 2010 IVD 221122 960 BIOPHEN Protein C 2.5 3x25 tests 2005 IVD 221202 2340 BIOPHEN Protein C 5 4x50 tests 2005 IVD 221205 6270 HYPHEN BIOMED代理 BIOPHEN Heparin Anti‐Xa (2 stages) 221010 优质...
Several heparin preparations have been assayed using the Denson and Bonnar anti-Xa assay. The heat defibrination step involved in this assay has been shown to introduce discrepancies into the results, due mainly to co-precipitation of the heparin with fibrinogen. The amount of heparin lost is de...
The anti- Xa-activity of the heparin applicated by jet injection was significantly higher (maximal effect after 3 hrs: 0.24 vs 0.20 USP heparin/ml plasma, p < 0.01, area under the time related curve p < 0.01). The data indicate, that the bioavailability of heparin for factor Xa is even...
The data suggest that specimens sent for anti-Xa require prompt handling to prevent falsely elevated values. This observation is new and future research is needed to find the mechanism of this alteration. 展开 关键词: factor Xa inhibitors in vitro diagnostic systems low-molecular-weight heparins ...
Changing a heparin order set to utilize anti Xa monitoring and to improve time to therapeutic anticoagulationMoyers, PTatro, JFerguson, TBall, JTimmons, C
Anti-FXa targets the key enzyme factor Xa in the coagulation cascade, inhibiting its function and preventing blood clot formation63. On the other hand, anti-FIIa targets another key participant in coagulation, thrombin. Increasing the ratio of anti-FXa to anti-FIIa is beneficial as it provides...